Literature DB >> 16888459

Testosterone prohormone supplements.

Gregory A Brown1, Matthew Vukovich, Douglas S King.   

Abstract

Testosterone prohormones such as androstenedione, androstenediol, and dehydroepiandrosterone (DHEA) have been heavily marketed as testosterone-enhancing and muscle-building nutritional supplements for the past decade. Concerns over the safety of prohormone supplement use prompted the United States Food and Drug Administration to call for a ban on androstenedione sales, and Congress passed the Anabolic Steroid Control Act of 2004, which classifies androstenedione and 17 other steroids as controlled substances. As of January 2005, these substances cannot be sold without prescription. Here, we summarize the current scientific knowledge regarding the efficacy and safety of prohormone supplementation in humans. We focus primarily on androstenedione, but we also discuss DHEA, androstenediol, 19-nor androstenedione, and 19-nor androstenediol supplements. Contrary to marketing claims, research to date indicates that the use of prohormone nutritional supplements (DHEA, androstenedione, androstenediol, and other steroid hormone supplements) does not produce either anabolic or ergogenic effects in men. Moreover, the use of prohormone nutritional supplements may raise the risk for negative health consequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888459     DOI: 10.1249/01.mss.0000228928.69512.2e

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  3 in total

1.  Complex interaction of religiousness with other factors in relation to substance use and misuse among female athletes.

Authors:  Mile Cavar; Damir Sekulic; Zoran Culjak
Journal:  J Relig Health       Date:  2012-06

Review 2.  Pharmacology of anabolic steroids.

Authors:  A T Kicman
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 3.  Medicinal Use of Testosterone and Related Steroids Revisited.

Authors:  Jan Tauchen; Michal Jurášek; Lukáš Huml; Silvie Rimpelová
Journal:  Molecules       Date:  2021-02-15       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.